Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth
- 10 October 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 97 (3) , 313-322
Abstract
Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are well‐known factors that induce neovascularization in many tumors. The molecular mechanisms that regulate tumor angiogenesis in human chondrosarcoma are not clear. We assessed in this work the angiogenic activities of a human chondrosarcoma cell line (OUMS‐27) in vivo and determined the efficacies of angiogenic factors derived from OUMS‐27 cells on human umbilical vein endothelial cells (HUVECs) in vitro. Tumor xenografts induced an increase in the formation of neovessels, but the distributions of Ki‐67 antigen, VEGF and bFGF were unaffected. We also demonstrated that OUMS‐27 cells secreted VEGF165 into the culture medium and that it was the maximal angiogenic factor to stimulate endothelial proliferation and migration in chondrosarcoma. Anti‐VEGF antibodies induced an approximately 70% inhibition of these responses of HUVECs, but did not have any effect on OUMS‐27 cells. Anti‐bFGF antibodies suppressed not only the activities of HUVECs but also the growth of tumor cells in vitro. We indicate that angiogenesis is principally elicited by VEGF165 and that tumorigenesis is mainly regulated by bFGF stored in the extracellular matrix of OUMS‐27 cells. The present study may offer the availability of combination therapies for inhibition of VEGF and bFGF action on vascular endothelial cells and chondrosarcoma cells, respectively.Keywords
This publication has 52 references indexed in Scilit:
- Growth plate chondrocytes inhibit neo-angiogenesis – a possible mechanism for tumor controlCancer Letters, 2001
- Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilageJournal of Anatomy, 1999
- Bone formation via cartilage models: The “borderline” chondrocyteMatrix Biology, 1998
- Identification of Chondromodulin I as a Novel Endothelial Cell Growth InhibitorJournal of Biological Chemistry, 1997
- Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8Biochimica et Biophysica Acta (BBA) - General Subjects, 1995
- Inhibition of tubular morphogenesis in human microvascular endothelial cells by co-culture with chondrocytes and involvement of transforming growth factor β: a model for avascularity in human cartilageBiochimica et Biophysica Acta (BBA) - General Subjects, 1994
- Identification of an Inhibitor of Neovascularization from CartilageScience, 1990
- Control of tumor growth in animals by infusion of an angiogenesis inhibitor.Proceedings of the National Academy of Sciences, 1980
- Tumor Cell Collagenase and Its Inhibition by a Cartilage-Derived Protease InhibitorScience, 1977
- Isolations of a Cartilage Factor That Inhibits Tumor NeovascularizationScience, 1976